European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?
Last/exit therapy with CladT seems to avoid MS disease reactivation in older PWMS and may be an interesting alternative solution to continue immunosuppression/immunomodulation.
Authors
- Xavier Ayrignac (ORCID: https://orcid.org/0000-0003-3834-2981)
- Pierre Labauge (ORCID: https://orcid.org/0000-0001-7759-8555)
- Jerome De Seze (ORCID: https://orcid.org/0000-0002-7197-7578)
- Kévin Bigaut (ORCID: https://orcid.org/0000-0002-5176-580X)
- Patrick Vermersch (ORCID: https://orcid.org/0000-0003-0997-8817)
- Christine Ernon
- Giulia Mallucci (ORCID: https://orcid.org/0000-0002-0031-9594)
- Claudio Gobbi (ORCID: https://orcid.org/0000-0002-7554-0664)
- Laurent Kremer (ORCID: https://orcid.org/0000-0002-6604-4458)
- Clarisse Carra‐Dallière (ORCID: https://orcid.org/0000-0002-0985-3662)
- Dominique Dive (ORCID: https://orcid.org/0000-0001-7982-9791)
- Livia Lanotte
- Chiara Zecca (ORCID: https://orcid.org/0000-0002-9990-3431)
- Éric Thouvenot (ORCID: https://orcid.org/0000-0001-8671-7747)
- Nicolas Collongues (ORCID: https://orcid.org/0000-0002-3683-5582)
- Giovanni Castelnovo
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Laboratory for Biomedical Neurosciences (CH)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Centre Hospitalier Universitaire de Liège (BE)
- Institut de Génomique Fonctionnelle (FR)
- Institute of Pharmacology (CZ)
- Università della Svizzera italiana (CH)
- Université de Strasbourg (FR)
Publication Details
- Journal
- Multiple Sclerosis Journal - Experimental Translational and Clinical
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/20552173251321810
- Citations
- 5
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.36